Sickle Erythrocytes Target Cytotoxics to Hypoxic Tumor Microvessels and Potentiate a Tumoricidal Response

• David S. Terman ,

  Contributed equally to this work with: David S. Terman, Benjamin L. Viglianti

  * E-mail: dst@sbcglobal.net (DST); mark.dewhirst@duke.edu (MWD)

  ¶These authors also contributed equally to this work.

  Affiliation Molecular Genetics Program, Jenomic, Carmel, California, United States of America

  ⨯
• Benjamin L. Viglianti ,

  Contributed equally to this work with: David S. Terman, Benjamin L. Viglianti

  Affiliation Department of Radiology, University of Michigan, Ann Arbor, Michigan, United States of America

  ⨯
• Rahima Zennadi,

  Affiliation Department of Medicine, Division of Hematology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Diane Fels,

  Affiliation Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Richard J. Boruta,

  Affiliation Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Hong Yuan,

  Affiliation Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, United States of America

  ⨯
• Mathew R. Dreher,

  Affiliation National Institutes of Health, Clinical Center, Diagnostic Radiology Department, Bethesda, Maryland, United States of America

  ⨯
• Gerald Grant,

  Affiliation Department of Surgery, Division of Neurosurgery, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Zahid N. Rabbani,

  Affiliation Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Ejung Moon,

  Affiliation Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Lan Lan,

  Affiliation Department of Biostatistics, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Joseph Eble,

  Affiliation Department of Radiology, Mayo Clinic Foundation, Rochester, Minnesota, United States of America

  ⨯
• Yiting Cao,

  Affiliation Department of Surgery, Division of Neurooncology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Brian Sorg,

  Affiliation Cancer Diagnosis Program, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Kathleen Ashcraft,

  Affiliation Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Greg Palmer,

  Affiliation Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Marilyn J. Telen,

  Affiliation Department of Medicine, Division of Hematology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
•  [ ... ],
• Mark W. Dewhirst

  * E-mail: dst@sbcglobal.net (DST); mark.dewhirst@duke.edu (MWD)

  ¶These authors also contributed equally to this work.

  Affiliation Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• [ view all ]
• [ view less ]